Botox Approved by FDA to Treat Overactive Bladder

by Kathy Jones on  January 21, 2013 at 6:11 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

The US Food and Drug Administration has approved Botox for treating overactive bladder in adult patients who have failed to respond to other treatments or are unable to tolerate them.
 Botox Approved by FDA to Treat Overactive Bladder
Botox Approved by FDA to Treat Overactive Bladder

Botox, manufactured by Allergen Inc, was initially developed as a cosmetic procedure but has since been approved in treating various conditions, including migraines, chronic focal neuropathies and squints.

Now a number of studies have found Botox to be beneficial in treating overactive bladder in adults.

"Clinical studies have demonstrated Botox's ability to significantly reduce the frequency of urinary incontinence. Today's approval provides an important additional treatment option for patients with overactive bladder, a condition that affects an estimated 33 million men and women in the United States", the director of the FDA's Division of Reproductive and Urologic Products, Hylton Joffe said.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Botox Vesico-Ureteric Reflux Causing UTI in Children Face Lift (Rhytidectomy) Interstitial Cystitis Anti-aging Secrets to a Younger You Cosmetic Surgery and the Risk Factors Wrinkles and Anti-Wrinkle Treatments 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive